- Home
- BDL vs AIDX Comparison
BDL vs AIDX Comparison
Compare BDL & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDL | AIDX |
|---|---|---|
| Founded | 1959 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.6M | 58.8M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDL | AIDX |
|---|---|---|
| Price | $34.42 | $2.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 573.0 | ★ 318.0K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | ★ 49.72 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $205,248,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $80.03 | ★ N/A |
| Revenue Growth | ★ 8.99 | N/A |
| 52 Week Low | $22.61 | $2.42 |
| 52 Week High | $35.98 | $14.09 |
Technical Indicators
Market Signals| Indicator | BDL | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 5.47 |
| Support Level | $29.56 | N/A |
| Resistance Level | $34.61 | $3.08 |
| Average True Range (ATR) | 0.29 | 0.82 |
| MACD | 0.07 | -0.17 |
| Stochastic Oscillator | 100.00 | 2.51 |
Price Performance
Historical ComparisonAbout BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.